GLAXOSMITHKLINE PHARMACEUTICALS
Back to Income Statement
|
GLAXOSMITHKLINE PHARMACEUTICALS Last 5 Year Revenue History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Net Sales | ₹3,822 Cr | ₹3,749 Cr | ₹3,454 Cr | ₹3,252 Cr | ₹3,278 Cr |
What is the latest Revenue of GLAXOSMITHKLINE PHARMACEUTICALS ?
| Year | Revenue |
|---|---|
| Mar2026 | ₹3,822 Cr |
| Mar2025 | ₹3,749 Cr |
| Mar2024 | ₹3,454 Cr |
| Mar2023 | ₹3,252 Cr |
| Mar2022 | ₹3,278 Cr |
How is Revenue of GLAXOSMITHKLINE PHARMACEUTICALS Trending?
| Years | Revenue | % Change | |
|---|---|---|---|
| Mar2026 | ₹3,822 Cr | 1.93 | |
| Mar2025 | ₹3,749 Cr | 8.56 | |
| Mar2024 | ₹3,454 Cr | 6.21 | |
| Mar2023 | ₹3,252 Cr | -0.80 | |
| Mar2022 | ₹3,278 Cr | - | |
Compare Revenue of peers of GLAXOSMITHKLINE PHARMACEUTICALS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| GLAXOSMITHKLINE PHARMACEUTICALS | ₹44,980.8 Cr | 9% | 7.7% | 4.2% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹452,707.0 Cr | 3.9% | 7.8% | 13% | Stock Analytics | |
| DIVIS LABORATORIES | ₹303,962.0 Cr | 11.5% | 20.6% | 68% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹179,494.0 Cr | 1% | 1.8% | 34.3% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹115,769.0 Cr | 1.1% | 11.8% | 14.9% | Stock Analytics | |
| CIPLA | ₹113,912.0 Cr | 1.1% | 7.9% | -6.3% | Stock Analytics | |
GLAXOSMITHKLINE PHARMACEUTICALS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| GLAXOSMITHKLINE PHARMACEUTICALS | 9% |
7.7% |
4.2% |
| SENSEX | 3.3% |
13.9% |
-1.7% |
You may also like the below Video Courses